治疗前体重指数对头颈癌患者生存的影响
该研究为一项前瞻性研究的二次分析,纳入2204例头颈部鳞状细胞癌(SCCHN)患者,按肿瘤人乳头瘤病毒(HPV)状态及亚部位分层,采用多变量Cox模型评估治疗前体重指数(BMI)与总生存、疾病特异性生存及无病生存的关联。结果显示BMI>25 kg/m2与生存改善相关,BMI<18.5 kg/m2与生存降低相关,尤其在HPV阳性口咽癌患者中。作者认为治疗前BMI可能是独立的预后因素,需进一步前瞻性研究。
要点
- 在SCCHN患者中,BMI>25 kg/m2与生存改善相关,BMI<18.5 kg/m2与生存降低相关。
- 上述关联尤其在HPV阳性口咽癌患者中明显。
- 治疗前BMI可能是SCCHN患者的独立预后因素,需进一步前瞻性研究。
核心结论
- 该探索性分析提示,治疗前BMI可能是SCCHN患者生存结局的独立预后因素,尤其在HPV阳性口咽癌患者中。
- 作者认为需进一步开展前瞻性研究。
研究设计与样本
- 研究为一项前瞻性研究的二次分析,共纳入2204例SCCHN患者。
- 采用多变量Cox模型评估治疗前BMI与总生存、疾病特异性生存及无病生存的关联,并按肿瘤HPV状态及亚部位对患者进行分层。
主要发现
- HPV阳性肿瘤患者的BMI显著高于HPV阴性肿瘤患者。
- BMI>25 kg/m2与生存改善相关,而BMI<18.5 kg/m2与生存降低相关,尤其在HPV阳性口咽癌患者中。
局限性
- 该研究为探索性分析,作者认为需进一步开展前瞻性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Differences in pretreatment body mass index (BMI) have been associated with survival in squamous cell carcinoma of head and neck (SCCHN). We examined effects of BMI on survival in SCCHN patients after stratifying patients by tumor human papillomavirus (HPV) status and subsite. METHODS: Totally 2204 SCCHN patients in a prospective study were included in this secondary analysis. Multivariable Cox models were used to evaluate associations between pretreatment BMI and overall survival, disease-specific survival, and disease-free survival. RESULTS: BMI was significantly higher among patients with HPV-positive tumors than HPV-negative tumors. BMI >25 kg/m2 was associated with improved survival, while BMI <18.5 kg/m2 was associated with reduced survival, particularly in patients with HPV-positive oropharyngeal cancer tumors. CONCLUSIONS: This exploratory analysis suggests that pretreatment BMI could be an independent prognostic factor of survival outcomes in SCCHN patients, particularly in patients with HPV-positive oropharyngeal cancer tumors. Further prospective investigations are warranted.
引用
- Yang Z, Mansour J, Sun P, et al. Impact of pretreatment body mass index on the survival of head and neck cancer patients. Head Neck. 2024. PMID: 38269627. doi:10.1002/hed.27659
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。